Assenagon Asset Management S.A. bought a new stake in Exponent, Inc. (NASDAQ:EXPO - Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 133,762 shares of the business services provider's stock, valued at approximately $9,993,000. Assenagon Asset Management S.A. owned 0.26% of Exponent at the end of the most recent quarter.
Other institutional investors have also recently added to or reduced their stakes in the company. Millennium Management LLC grew its stake in shares of Exponent by 543.1% in the first quarter. Millennium Management LLC now owns 305,230 shares of the business services provider's stock valued at $24,742,000 after buying an additional 257,766 shares in the last quarter. Cubist Systematic Strategies LLC purchased a new position in Exponent in the 1st quarter worth approximately $15,349,000. Geneva Capital Management LLC grew its position in Exponent by 11.2% in the first quarter. Geneva Capital Management LLC now owns 1,745,828 shares of the business services provider's stock valued at $141,517,000 after acquiring an additional 176,152 shares in the last quarter. Jacobs Levy Equity Management Inc. purchased a new stake in shares of Exponent during the first quarter valued at approximately $12,686,000. Finally, Nuveen LLC purchased a new stake in shares of Exponent during the first quarter valued at approximately $10,828,000. 92.37% of the stock is owned by hedge funds and other institutional investors.
Insider Activity
In other Exponent news, CEO Catherine Corrigan sold 4,905 shares of the company's stock in a transaction dated Monday, September 15th. The shares were sold at an average price of $69.91, for a total value of $342,908.55. Following the completion of the sale, the chief executive officer directly owned 82,753 shares of the company's stock, valued at approximately $5,785,262.23. This represents a 5.60% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, VP Joseph Sala sold 1,595 shares of the stock in a transaction on Tuesday, August 12th. The shares were sold at an average price of $70.64, for a total value of $112,670.80. The disclosure for this sale can be found here. Insiders have sold 11,396 shares of company stock valued at $803,636 in the last 90 days. Insiders own 1.60% of the company's stock.
Exponent Price Performance
NASDAQ:EXPO opened at $68.88 on Wednesday. The firm has a 50-day moving average of $70.89 and a two-hundred day moving average of $75.50. The stock has a market cap of $3.48 billion, a P/E ratio of 34.44 and a beta of 0.94. Exponent, Inc. has a 1-year low of $63.81 and a 1-year high of $115.75.
Exponent (NASDAQ:EXPO - Get Free Report) last announced its quarterly earnings data on Thursday, July 31st. The business services provider reported $0.52 earnings per share for the quarter, topping the consensus estimate of $0.48 by $0.04. Exponent had a net margin of 18.35% and a return on equity of 24.19%. The company had revenue of $132.87 million during the quarter, compared to analyst estimates of $130.82 million. During the same period last year, the business earned $0.57 EPS. The firm's revenue for the quarter was up 7.3% compared to the same quarter last year. As a group, equities analysts expect that Exponent, Inc. will post 1.98 earnings per share for the current year.
Exponent Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Friday, September 19th. Stockholders of record on Friday, September 5th were issued a dividend of $0.30 per share. The ex-dividend date of this dividend was Friday, September 5th. This represents a $1.20 annualized dividend and a dividend yield of 1.7%. Exponent's payout ratio is 60.00%.
Exponent Profile
(
Free Report)
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
See Also
Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent, Inc. (NASDAQ:EXPO - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Exponent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.
While Exponent currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.